Status:
TERMINATED
Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics
Lead Sponsor:
Nantes University Hospital
Conditions:
Asthma
Chronic Inflammatory Diseases
Eligibility:
All Genders
18-90 years
Brief Summary
Asthma is a chronic inflammatory disease, affecting up to 10 % of the general population in developed countries. Corticosteroids are necessary to control symptoms, but induce adverse events sometimes ...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Male or female adults aged ≥ 18 years, who have signed an Inform Consent Form prior to initiation of any study-related procedure
- Patients with severe asthma with at least 2 exacerbations during the last 12 months that necessitated oral cortico-therapy or increase in oral cortico-therapy
- Exclusion criteria :
- Pregnant or nursing women
- Patients with other chronic inflammatory lung disease
- Current smoker or a smoking history of 10 pack years or more
Exclusion
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00721097
Start Date
June 1 2008
End Date
May 1 2011
Last Update
September 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
nantes University Hospital
Nantes, Nantes, France, 44093